期刊文献+

丙泊酚持续恒速输注在大鼠无肝期血药浓度的变化及意义

Changes and meanings of propofol blood concentrations in rat during anhepatic phase by continuous steady-rate infusion
下载PDF
导出
摘要 目的探讨丙泊酚持续恒速输注在大鼠无肝期前后血药浓度变化规律、肝外代谢、肺脏对丙泊酚肝外代谢的作用。方法通过左颈深静脉持续恒速输注丙泊酚,于分离肝门时、肝门阻断即刻、肝门阻断15、30、60min等时间点,同时从右侧颈深动、静脉分别采血(100μl),采用高效液相色谱荧光法(HPLC)检测丙泊酚血药浓度。结果颈深静脉或颈深动脉丙泊酚血药浓度各时相点间比较,肝门阻断15、30、60min时的血药浓度比阻断前和阻断即刻明显升高(P<0.01),但三者间没有显著性差异(P>0.05);颈深静脉与颈深动脉丙泊酚血药浓度比较,任何时刻没有显著性差异(P>0.05)。结论肝脏是丙泊酚主要代谢器官,丙泊酚存在肝外代谢,肺脏不是丙泊酚肝外代谢的主要器官。 Objective To observe the changes of propofol blood concentrations in rat during anhepatic phase by continuous steady-rate infusion to confirm the extrahepatic metabolism of propofol and to show the effect of lungs for propofol in the extrahepatic metabolism. Methods Continuous steady-rate transfuse propofol by left deep cervical vein, blood samples(100μl) were taken simultaneously from right the deep cervical artery and vein at the fllowing times: hepatic portal dissociation,immediate devascularization of the hepatic portal, 15min and 30min and 60min post-devascularization of the hepatic portal, propofol blood concentrations was analysed by HPLC. Results At 15min. 30min and 60min post devascularization of the hepatic portal,the propofol blood concentrations in the right deep cervical artery and vein were significantly higher than those the times of hepatic portal dissociation and immediate devascularization of the hepatic portal(P〈0.01 ), the blood concentrations of propofol were no significantly differences at the three times of post devascularization of the hepatic portal (P〉0.05). The blood concentrations of propofol in the deep cervical between artery and vein were no significantly differences at any times(P〉0.05). Conclusion The liver is main organ of propofol metabolism. Extrahepatic metabolism of propofol is existence. Lung is not main organ of propofol extrahepatic metabolism.
出处 《重庆医学》 CAS CSCD 2005年第10期1485-1486,共2页 Chongqing medicine
关键词 丙泊酚 无肝期 肝外代谢 propofol anhepatic phase extrahepatic metabolism
  • 相关文献

参考文献10

  • 1蒋静敏,汤伟.异丙酚用于全麻诱导及维持[J].重庆医学,1998,27(6):383-384. 被引量:1
  • 2Langley MS, Heel RC. Propofol:a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic[J]. Drugs, 1988,35:334 被引量:1
  • 3Verli P, O'kelly B, Bertrand F,et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation[J]. Br J Anaesth, 1992,68:183 被引量:1
  • 4Knibbe CAJ, Koster VA, Deneer VHM,et al. Determination of propofol in low-volume samples by high-performanc liquid chromatography with fluorescence detection[J]. J Chrom Biomed Sci Appl, 1998, 706:305 被引量:1
  • 5Adam HK, Glen JB, Hoyle PA. Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent[J]. Br J Anaesthesia, 1980, 52(8): 743 被引量:1
  • 6Raoff AA, van-Obbergh LJ, de-Ville-de-Goyet J, et al.Extrahepatic glucuronidation of propofol in man: possible contriburion of gut wall and kidney[J]. Eur J Clin Pharmacol, 1996, 50:91 被引量:1
  • 7Kuipers JA, Boer F, Olieman W, et al. First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model[J]. Anesthesiology, 1999, 91(6): 1780 被引量:1
  • 8古妙宁,盖成林,林春水,欧阳铭文,徐建设,周俊岭.恒速静脉输注异丙酚时脑摄取的研究[J].中华麻醉学杂志,2001,21(3):133-135. 被引量:16
  • 9Zhang SH, Li Q, Yao SL. Subcellular expression of UGT1A6 and CYP1A1 responsible for propofol metabolism in human brain[J]. Acta Pharmacol Sin, 2001, 22(11):1013 被引量:1
  • 10Le Guellec C, Lacarelle B, Villard PH, et al. Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs[J]. Anesth Analg, 1995, 81:855 被引量:1

二级参考文献1

  • 1Richard N. Upton,Laurence E. Mather,William B. Runciman,Craig Nancarrow,Ronda J. Carapetis. The use of mass balance principles to describe regional drug distribution and elimination[J] 1988,Journal of Pharmacokinetics and Biopharmaceutics(1):13~29 被引量:1

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部